I am/have/had
I am looking for
Advanced Filters
Found 242 clinical trials
The Effect of Hepatic Impairment on Aprocitentan Pharmacokinetics
This is a prospective, single-center, open-label, single-dose, Phase 1 study, to assess the effect of moderate hepatic impairment due to liver cirrhosis on the pharmacokinetics of aprocitentan (ACT-132577).
hepatic impairment
body mass index
aprocitentan
follicle stimulating hormone
diastolic blood pressure
- 0 views
- 16 Feb, 2024
- 1 location
A Study of Oral Tazemetostat in Subjects With Moderate and Severe Hepatic Impairment With Advanced Malignancies
This is a phase 1, 2-part, global, multicenter, open-label, PK, safety and tolerability study of oral tazemetostat in subjects with either advanced solid tumors, or hematological malignancies and normal hepatic function or moderate, or severe hepatic impairment.
hepatic impairment
targeted therapy
HIV Infection
lymphoma
hiv viral load
- 0 views
- 16 Feb, 2024
- 5 locations